Gastrointestinal Stents Market Is Expanding Rapidly With Amg International Gmbh Receiving CE Mark Approval for Unity-B Balloon-Expandable Biodegradable Biliary Stent for Endoscopic Use

Gastrointestinal Stents, also known as Stent Frames, are a method of dilating the lower intestine to prevent absorption of food. In the passing of food from the stomach into the small intestines there are several obstacles that slow down the movement of the food. As cases of digestive diseases surge, the demand for gastrointestinal stents continues to increase. Major digestive diseases include gastrointestinal reflux disease (GERD), Crohn’s disease, and ulcerative colitis. As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 20% of adults in western culture are affected with GERD. According to the same source, the prevalence of GERD in the U.S. was between 18.1% and 27.8% in 2020. Such a high prevalence of GERD has necessitated the adoption of adequate treatment measures. Hence, these factors can stimulate growth of the gastrointestinal stents market.

The Gastrointestinal Stent market will grow at a CAGR 4.7% over the following five years.

LIMITED TIME OFFER – Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount for Buyers USD 2000 OFF On Any Research Report

Buy Now and Get Instant Discount: https://www.coherentmarketinsights.com/promo/buynow/1756

Gastrointestinal Stent Market Segmentation:
Gastrointestinal Stent Market, By Application (2016-2027)
Hospital
Medical Center

Gastrointestinal Stent Market, By Product (2016-2027)
Fully Covered Gastrointestinal Stents
Partially Covered Gastrointestinal Stents
Non-Covered Gastrointestinal Stents

Major Players Operating in the Gastrointestinal Stent Market:
Boston Scientific
Cook Medical
Teleflex
C.R. Bard

When it comes to regional influence, North America seems to be exhibiting lucrative signs in the gastrointestinal stents market. This can be attributed to growing adoption of minimally invasive surgeries and favorable reimbursement policies in the U.S. and Canada. On the contrary, Asia Pacific is exhibiting a positive outlook due to rapidly expanding medical tourism industry in emerging economies. Recently, in May 2021, amg International GmbH, a subsidiary of Q3 Medical Devices Limited (Q3), received CE Mark approval for Unity-B balloon-expandable biodegradable biliary stent for endoscopic use.

Gastrointestinal Stents are introduced into the abdomen either through surgical procedures or the use of medicines. Patients suffering from malabsorptive conditions such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBR), are often advised to undergo surgery for the treatment of their ulcerative colitis, Crohn's disease, or irritable bowel syndrome before applying Gastrointestinal Stents. Regardless of these advantageous factors, there are certain complications associated with these stents such as retrosternal pain, perforation, and stent migration, which could impede growth of the gastrointestinal stents market. Besides, a stringent regulatory framework could limit the market growth.

One of the main complications associated with Gastrointestinal Stents is perforation of the stomach. Perforation of the stomach is a serious problem since it can cause death. In the majority of cases, the patient will experience immediate symptoms after undergoing an Epochlor hydrochloride ulcerative procedure. Symptoms include abdominal pain, vomiting, and nausea. With technological advancements in medical science, medical professionals are increasingly preferring minimally invasive procedures. These procedures offer numerous advantages such as fewer operations, less scarring, smaller incision, and shortened hospital stay. As a result of this, the demand for gastrointestinal stents is as they offer minimally invasive techniques. Hence, these factors could boost growth of the gastrointestinal stents market.

Read more @ https://www.coherentmarketinsights.com/ongoing-insight/gastrointestinal-stents-market-1756

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle,
WA 98154, U.S.
Phone:
US: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com

About Us:
Coherent Market Insights (CMI) is a global market intelligence and consulting organization focused on assisting plethora of clients achieve transformational growth by helping them make critical business decisions. The company is headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. The company’s client base includes players from across various business verticals in over 47 countries globally. It takes pride in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and start-ups looking to establish a foothold in the market.

This release was published on openPR.